![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgUNfbBGk_ro4O9ksJ_a4I7i06sGU2lbrtp26Qt9UL69kI0kZ9dCcE15q0AxmjIAGYvfrpezACU4Gfb4Iyk6jlLS8qfMkkrrdOfsg7qig8R7NdTW59IIUZ_aiWq68KwgQzzTTCLnl4qtgms/s1600/MAnderson.jpg) |
Matthew Anderson, MD, PhD |
Dr. Matt Anderson, chief of neuropathology at Beth Israel in Boston, forwarded me a
recent article from The Scientist. The article describes the experience of
Alessandro Laurenzi, a biologist working in Bologna, Italy, regarding the proposition that COVID-19 infected patients can have transient loss of the sense of smell. Olfactory sensory loss may play a role in early diagnosis, but it may also help in understanding pathogensis.
Dr. Anderson is quoted in the article, stating that central nervous system involvement by the virus may play a part in the respiratory symptomatology.